Review





Similar Products

intravitreal dexamethasone implant  (Allergan)
86
Allergan intravitreal dexamethasone implant
Intravitreal Dexamethasone Implant, supplied by Allergan, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/dexamethasone/pmc13147599-50-0-8
Average 86 stars, based on 1 article reviews
intravitreal dexamethasone implant - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
sustained release dexamethasone implant  (Allergan)
86
Allergan sustained release dexamethasone implant
Sustained Release Dexamethasone Implant, supplied by Allergan, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/dexamethasone+implant+release+sustained/pm41753344-33-3-7
Average 86 stars, based on 1 article reviews
sustained release dexamethasone implant - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
dexamethasone implants  (Allergan)
86
Allergan dexamethasone implants
Progression of retinal arterial vasospasm in central retinal vein occlusion (CRVO): baseline and follow-up imaging. a Wide-field color fundus photography of a 59-year-old patient with CRVO and hypertension showing arterial vasospasm (yellow arrow). b Spectral-domain optical coherence tomography (SD-OCT) image of the same patient demonstrating macular edema. c Wide-field fluorescein angiography (FA) image at 22 s demonstrating more clearly delineated arterial vasospasm (yellow arrows). d Wide-field FA image at 18 s obtained 5 months after four intravitreal injections (two bevacizumab [Avastin ® ; Genentech, Inc., San Francisco, CA] and two <t>dexamethasone</t> implants [Ozurdex ® ; Allergan Inc., Irvine, CA]), showing progression of arterial vasospasm (yellow arrows)
Dexamethasone Implants, supplied by Allergan, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/dexamethasone/pmc12976225-66-161-166
Average 86 stars, based on 1 article reviews
dexamethasone implants - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
dexamethasone implant  (Allergan)
86
Allergan dexamethasone implant
Progression of retinal arterial vasospasm in central retinal vein occlusion (CRVO): baseline and follow-up imaging. a Wide-field color fundus photography of a 59-year-old patient with CRVO and hypertension showing arterial vasospasm (yellow arrow). b Spectral-domain optical coherence tomography (SD-OCT) image of the same patient demonstrating macular edema. c Wide-field fluorescein angiography (FA) image at 22 s demonstrating more clearly delineated arterial vasospasm (yellow arrows). d Wide-field FA image at 18 s obtained 5 months after four intravitreal injections (two bevacizumab [Avastin ® ; Genentech, Inc., San Francisco, CA] and two <t>dexamethasone</t> implants [Ozurdex ® ; Allergan Inc., Irvine, CA]), showing progression of arterial vasospasm (yellow arrows)
Dexamethasone Implant, supplied by Allergan, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant/dexamethasone/pmc12860817-144-4-7
Average 86 stars, based on 1 article reviews
dexamethasone implant - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


Progression of retinal arterial vasospasm in central retinal vein occlusion (CRVO): baseline and follow-up imaging. a Wide-field color fundus photography of a 59-year-old patient with CRVO and hypertension showing arterial vasospasm (yellow arrow). b Spectral-domain optical coherence tomography (SD-OCT) image of the same patient demonstrating macular edema. c Wide-field fluorescein angiography (FA) image at 22 s demonstrating more clearly delineated arterial vasospasm (yellow arrows). d Wide-field FA image at 18 s obtained 5 months after four intravitreal injections (two bevacizumab [Avastin ® ; Genentech, Inc., San Francisco, CA] and two dexamethasone implants [Ozurdex ® ; Allergan Inc., Irvine, CA]), showing progression of arterial vasospasm (yellow arrows)

Journal: Ophthalmology and Therapy

Article Title: Retinal Arterial Vasospasm in Retinal Vein Occlusion and Its Association with Aqueous Humor Endothelin-1

doi: 10.1007/s40123-026-01330-3

Figure Lengend Snippet: Progression of retinal arterial vasospasm in central retinal vein occlusion (CRVO): baseline and follow-up imaging. a Wide-field color fundus photography of a 59-year-old patient with CRVO and hypertension showing arterial vasospasm (yellow arrow). b Spectral-domain optical coherence tomography (SD-OCT) image of the same patient demonstrating macular edema. c Wide-field fluorescein angiography (FA) image at 22 s demonstrating more clearly delineated arterial vasospasm (yellow arrows). d Wide-field FA image at 18 s obtained 5 months after four intravitreal injections (two bevacizumab [Avastin ® ; Genentech, Inc., San Francisco, CA] and two dexamethasone implants [Ozurdex ® ; Allergan Inc., Irvine, CA]), showing progression of arterial vasospasm (yellow arrows)

Article Snippet: Fig. 1 Multimodal imaging of retinal arterial vasospasm in branch retinal vein occlusion (BRVO). a Wide-field color fundus photography of a 57-year-old male with hypertension and dyslipidemia, showing arterial vasospasm (yellow arrows) in an eye with BRVO. b Corresponding wide-field fluorescein angiography image at 18 s demonstrating more clearly delineated arterial vasospasm (yellow arrows). c Spectral-domain optical coherence tomography (SD-OCT) image of the same patient showing significant macular edema Fig. 2 Progression of retinal arterial vasospasm in central retinal vein occlusion (CRVO): baseline and follow-up imaging. a Wide-field color fundus photography of a 59-year-old patient with CRVO and hypertension showing arterial vasospasm (yellow arrow). b Spectral-domain optical coherence tomography (SD-OCT) image of the same patient demonstrating macular edema. c Wide-field fluorescein angiography (FA) image at 22 s demonstrating more clearly delineated arterial vasospasm (yellow arrows). d Wide-field FA image at 18 s obtained 5 months after four intravitreal injections (two bevacizumab [Avastin ® ; Genentech, Inc., San Francisco, CA] and two dexamethasone implants [Ozurdex ® ; Allergan Inc., Irvine, CA]), showing progression of arterial vasospasm (yellow arrows)

Techniques: Imaging, Tomography